Intervention Review

You have free access to this content

Advice to reduce dietary salt for prevention of cardiovascular disease

  1. Lee Hooper1,*,
  2. Christopher Bartlett2,
  3. George Davey Smith3,
  4. Shah Ebrahim4

Editorial Group: Cochrane Hypertension Group

Published Online: 26 JAN 2004

Assessed as up-to-date: 25 NOV 2003

DOI: 10.1002/14651858.CD003656.pub2


How to Cite

Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Advice to reduce dietary salt for prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003656. DOI: 10.1002/14651858.CD003656.pub2.

Author Information

  1. 1

    University of East Anglia, School of Medicine, Health Policy & Practice, Norwich, UK

  2. 2

    North Swindon District Centre, Swindon Primary Care Trust, Swindon, Wiltshire, UK

  3. 3

    University of Bristol, Department of Social Medicine, Bristol, UK

  4. 4

    London School of Hygiene & Tropical Medicine, Department of Epidemiology & Population Health, London, UK

*Lee Hooper, School of Medicine, Health Policy & Practice, University of East Anglia, Norwich, NR4 7TJ, UK. l.hooper@uea.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 26 JAN 2004

SEARCH

[Analysis 1.1]
Analysis 1.1. Comparison 1 Mortality and cardiovascular morbidity, Outcome 1 Mortality.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Mortality and cardiovascular morbidity, Outcome 2 Cardiovascular morbidity.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Systolic blood pressure, Outcome 1 Trials with 6 to 12 months of follow up.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Systolic blood pressure, Outcome 2 Trials with 13 to 60 months of follow up.
[Analysis 2.3]
Analysis 2.3. Comparison 2 Systolic blood pressure, Outcome 3 Trials with more than 60 months of follow up.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Diastolic blood pressure, Outcome 1 Trials with 6 to 12 months of follow up.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Diastolic blood pressure, Outcome 2 Trials with 13 to 60 months of follow up.
[Analysis 3.3]
Analysis 3.3. Comparison 3 Diastolic blood pressure, Outcome 3 Trials with more than 60 months of follow up.
[Analysis 4.1]
Analysis 4.1. Comparison 4 Urinary sodium excretion, Outcome 1 Urinary sodium excretion at different times following intervention.
[Analysis 5.1]
Analysis 5.1. Comparison 5 Dropouts, Outcome 1 Comparison of dropouts at longest follow up.